9 March 2021

Women in Europe lack access to HIV prevention drug PrEP

Despite its proven effectiveness in preventing HIV infection, pre-exposure prophylaxis (PrEP) is rarely used by women in Europe. Moreover, recent research shows that women in Europe lack sufficient access to this preventative medication. The study also found that women at risk of HIV infection are indeed interested in the use of oral PrEP. ‘Women should also be able to protect themselves in this way against HIV, because their sex partners often don’t pay attention to it,’ says Kai Jonas, professor of Applied Social Psychology at Maastricht University.